🇺🇸 FDA

Company profile · Sponsor

Chemomab

Chemomab Therapeutics

CMMB · NYSE pharma TEL AVIV, USA
Pipeline
6
Drugs
0
Patents
4

Quick answer

Chemomab (CMMB) is a pharma company. headquartered in TEL AVIV, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker CMMB
Exchange NYSE
Company type pharma
Headquarters TEL AVIV, USA
SEC CIK 0001534248

Pipeline (6)

Search pipeline →

  1. 10 mg/kg CM-101

    Chemomab

    Systemic Sclerosis

    phase 2 small molecule on hold

    1 trial

  2. 5 mg/kg CM-101

    Chemomab

    Nonalcoholic Steatohepatitis

    phase 2 mab completed

    1 trial

  3. Anti-human CCL24 monoclonal antibody (CM-101)

    Chemomab

    Primary Sclerosing Cholangitis

    phase 2 mab active

    1 trial

  4. Anti-human CCL24 monoclonal antibody (CM-101)

    Chemomab

    Healthy

    phase 1 small molecule completed

    1 trial

  5. Anti-human CCL24 monoclonal antibody (CM-101) - Part One

    Chemomab

    Nonalcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  6. CM-101

    Chemomab

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

Patents (4)

Search patents →

  1. US 12018074

    Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11365246

    Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10479830

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10246508

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Chemomab?

Chemomab (CMMB) is a pharma company. headquartered in TEL AVIV, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does Chemomab sponsor?

We track 6 ClinicalTrials.gov-linked programs for Chemomab, including 10 mg/kg CM-101 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Chemomab company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.